http://rdf.ncbi.nlm.nih.gov/pubchem/reference/7395971

Outgoing Links

Predicate Object
contentType Journal Article
endingPage 1992
issn 1549-9634
issueIdentifier 6
pageRange 1983-1992
publicationName Nanomedicine : nanotechnology, biology, and medicine
startingPage 1983
hasFundingAgency http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_77e2488754b2b37f99f84e3d30d28ece
http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_c2de62851aee5825eefb200d2346ccd5
isSupportedBy http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_5d4ff7c141367f926df7b9a24ac0eed5
http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_6eada3f9c59737ec3fb696dc5c6e02dd
bibliographicCitation Garbuzenko OB, Ivanova V, Kholodovych V, Reimer DC, Reuhl KR, Yurkow E, Adler D, Minko T. Combinatorial treatment of idiopathic pulmonary fibrosis using nanoparticles with prostaglandin E and siRNA(s). Nanomedicine: Nanotechnology, Biology and Medicine. 2017 Aug;13(6):1983–92. doi: 10.1016/j.nano.2017.04.005.
creator http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_702de06bd633bd32a487741cf936f90b
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_148685ed6bcfd87c915ff74dcf0f5f59
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_8e283d6e9d7f39420d18d1f0f3fbc916
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_affa17f51efc1819051587efc1fd6396
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_92e2661a2c20973b2194e14b84f3be5b
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_881ce2a404e4d27634d8c52cf5031e40
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_bcbe78d55b0863b72a4e14c3a503a6b4
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_dc161556f34776a6131b9d35b8ae7325
date 201708
identifier https://doi.org/10.1016/j.nano.2017.04.005
https://pubmed.ncbi.nlm.nih.gov/PMC5546883
https://pubmed.ncbi.nlm.nih.gov/28434932
isPartOf http://rdf.ncbi.nlm.nih.gov/pubchem/journal/32817
https://portal.issn.org/resource/ISSN/1549-9634
language English
source https://www.crossref.org/
https://pubmed.ncbi.nlm.nih.gov/
title Combinatorial treatment of idiopathic pulmonary fibrosis using nanoparticles with prostaglandin E and siRNA(s)
discusses http://id.nlm.nih.gov/mesh/M0017805
http://id.nlm.nih.gov/mesh/M0406100
http://id.nlm.nih.gov/mesh/M0012553
http://id.nlm.nih.gov/mesh/M0002657
http://id.nlm.nih.gov/mesh/M0001348
hasPrimarySubjectTerm http://id.nlm.nih.gov/mesh/D011453Q000627
http://id.nlm.nih.gov/mesh/D053758Q000008
http://id.nlm.nih.gov/mesh/D016503Q000379
http://id.nlm.nih.gov/mesh/D054990Q000628
http://id.nlm.nih.gov/mesh/D034741Q000008
hasSubjectTerm http://id.nlm.nih.gov/mesh/D051379
http://id.nlm.nih.gov/mesh/D034741Q000235
http://id.nlm.nih.gov/mesh/D054990Q000235
http://id.nlm.nih.gov/mesh/D001761Q000494
http://id.nlm.nih.gov/mesh/D000818
http://id.nlm.nih.gov/mesh/D003131
http://id.nlm.nih.gov/mesh/D000280
http://id.nlm.nih.gov/mesh/D000903Q000494
http://id.nlm.nih.gov/mesh/D054990Q000473
http://id.nlm.nih.gov/mesh/D008812
http://id.nlm.nih.gov/mesh/D008055Q000737
discussesAsDerivedByTextMining http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_0f7897891f9d912ba3656f4d7e0e9fad
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID84068
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5280360
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID155903698
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID11094
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID456190
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5460769
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5360373
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID10071
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5810

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID53788293
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID53789659

Total number of triples: 63.